Autologous Stem Cell Transplantation for Patients With Recurrent Nasopharyngeal Carcinoma

Stopped early · Phase 3

Conditions studied: Recurrent Nasopharynx Carcinoma

In brief

This is a pilot study to evaluate the response rates for patients undergoing high dose conditioning chemotherapy using Etoposide, Carboplatin and Ifosfamide followed by autologous stem cell transplantation for the treatment of recurrent Nasopharyngeal Cancer (NPC) in children, adolescents, and young adults.

Key facts

Study ID

NCT02137096

Run by

University of Florida

People needed

1

Starts

2014-06-01

Expected to finish

2017-05-09

Last updated by the study team

2019-06-24

Who can join

Age: 2 and older, up to 30. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Imaging and tissue diagnosis of recurrent or progressive nasopharyngeal carcinoma
• Documentation of previous treatment including conventional chemotherapy and/or radiation therapy as clinically appropriate
• Ages 2 to 30 years of age
• Negative serum pregnancy test if applicable
• Calculated creatinine clearance of greater than 60 mL/minute, serum creatinine of less than 12o micromoles/L, total bilirubin less than 2 mg/dL and aspartate aminotransferase (AST) must be less than twice the upper limit of normal

You may not qualify if…

• Unsuitable candidate for autologous transplantation due to comorbidities or intractable psychosocial issues
• Pregnancy
• Breast-feeding women

Where it is running

• UF Health Shands Hospital — Gainesville, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.